BioAtla Ownership 2024 | Who Owns BioAtla Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

46.01%

Insider Ownership

10.76%

Retail Ownership

43.23%

Institutional Holders

81.00

BioAtla Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SOLEUS CAPITAL MANAGEMENT, L.P.8.11%0.47%3,901,314-163,883-4.03%5,344,800Jun 30, 2024
VANGUARD GROUP INC3.92%-1,885,252-213,785-10.18%2,582,795Jun 30, 2024
MORGAN STANLEY3.86%0.00%1,854,768-55,376-2.90%2,541,032Jun 30, 2024
MILLENNIUM MANAGEMENT LLC3.43%0.00%1,649,262775,60888.78%2,259,489Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC2.86%0.19%1,374,076-100,000-6.78%1,882,484Jun 30, 2024
DEUTSCHE BANK AG\2.49%0.00%1,195,353-48,894-3.93%1,637,634Jun 30, 2024
BLACKROCK INC.1.65%-791,560-1,988,141-71.52%1,084,438Jun 30, 2024
BOXER CAPITAL, LLC1.43%0.05%686,347--940,295Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC1.32%0.00%636,136636,136100.00%871,507Jun 30, 2024
SCION ASSET MANAGEMENT, LLC1.32%1.65%633,959633,959100.00%868,524Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC1.30%0.00%625,500-370,800-37.22%856,935Jun 30, 2024
MASSACHUSETTS FINANCIAL SERVICES CO /MA/1.13%0.00%541,19914,7372.80%741,443Jun 30, 2024
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND1.07%0.00%512,300--701,851Jun 30, 2024
NORGES BANK1.02%0.00%488,191488,191100.00%668,822Jun 30, 2024
MAI CAPITAL MANAGEMENT0.99%0.01%477,619147,22444.56%654,338Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.84%-404,565-518,373-56.17%554,397Jun 30, 2024
BANK OF MONTREAL /CAN/0.84%0.00%404,198143,52155.06%626,507Jun 30, 2024
GOLDMAN SACHS GROUP INC0.75%0.00%358,920311,736660.68%491,720Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.69%0.00%333,85873,59828.28%458,117Jun 30, 2024
NORTHERN TRUST CORP0.68%0.00%327,544-26,396-7.46%448,736,000Jun 30, 2024

BioAtla's largest institutional shareholder is SOLEUS CAPITAL MANAGEMENT, L.P., holding 8.11% of the company's total share outstanding, currently valued at $5.34M. The top 10 institutional shareholders own together 30.38% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SCION ASSET MANAGEMENT, LLC1.32%1.65%633,959633,959100.00%868,524Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.8.11%0.47%3,901,314-163,883-4.03%5,344,800Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC2.86%0.19%1,374,076-100,000-6.78%1,882,484Jun 30, 2024
BOXER CAPITAL, LLC1.43%0.05%686,347--940,295Jun 30, 2024
ALPINE GLOBAL MANAGEMENT, LLC0.32%0.04%154,417154,417100.00%211,551Jun 30, 2024
MYDA ADVISORS LLC0.21%0.03%100,000-80,000-44.44%137,000Jun 30, 2024
GROUND SWELL CAPITAL, LLC0.05%0.03%24,06324,063100.00%32,966Jun 30, 2024
FORMIDABLE ASSET MANAGEMENT, LLC0.22%0.02%104,438-40,736-28.06%143,080Jun 30, 2024
SC&H FINANCIAL ADVISORS, INC.0.14%0.02%65,519--89,761Jun 30, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.0.15%0.02%72,19372,193100.00%98,905Jun 30, 2024
XTX TOPCO LTD0.30%0.02%144,583-19,784-12.04%198,079Jun 30, 2024
CORNERCAP INVESTMENT COUNSEL INC0.13%0.01%60,611-589-0.96%83,037Jun 30, 2024
RINKEY INVESTMENTS0.05%0.01%25,31025,310100.00%34,675Jun 30, 2024
Y-INTERCEPT (HONG KONG) LTD0.34%0.01%161,871161,871100.00%221,763Jun 30, 2024
TWIN LAKES CAPITAL MANAGEMENT, LLC0.02%0.01%10,500--14,385Jun 30, 2024
MAI CAPITAL MANAGEMENT0.99%0.01%477,619147,22444.56%654,338Jun 30, 2024
PALOMA PARTNERS MANAGEMENT CO0.20%0.00%97,17697,176100.00%133,131Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.19%0.00%90,000--123,300Jun 30, 2024
MYDA ADVISORS LLC0.02%0.00%8,000--10,960Jun 30, 2024
UNITED BANK0.03%0.00%13,00013,000100.00%17,810Jun 30, 2024

The largest BioAtla shareholder by % of total assets is SCION ASSET MANAGEMENT, LLC. The company owns 633.96K shares of BioAtla (BCAB), representing 1.65% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MILLENNIUM MANAGEMENT LLC3.43%0.00%1,649,262775,60888.78%2,259,489Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC1.32%0.00%636,136636,136100.00%871,507Jun 30, 2024
SCION ASSET MANAGEMENT, LLC1.32%1.65%633,959633,959100.00%868,524Jun 30, 2024
NORGES BANK1.02%0.00%488,191488,191100.00%668,822Jun 30, 2024
GOLDMAN SACHS GROUP INC0.75%0.00%358,920311,736660.68%491,720Jun 30, 2024
Y-INTERCEPT (HONG KONG) LTD0.34%0.01%161,871161,871100.00%221,763Jun 30, 2024
ALPINE GLOBAL MANAGEMENT, LLC0.32%0.04%154,417154,417100.00%211,551Jun 30, 2024
MAI CAPITAL MANAGEMENT0.99%0.01%477,619147,22444.56%654,338Jun 30, 2024
BANK OF MONTREAL /CAN/0.84%0.00%404,198143,52155.06%626,507Jun 30, 2024
GROUP ONE TRADING, L.P.0.24%0.00%114,866103,370899.18%157,366,000Jun 30, 2024
PALOMA PARTNERS MANAGEMENT CO0.20%0.00%97,17697,176100.00%133,131Jun 30, 2024
CENTIVA CAPITAL, LP0.19%0.00%90,40090,400100.00%123,848Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.69%0.00%333,85873,59828.28%458,117Jun 30, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.0.15%0.02%72,19372,193100.00%98,905Jun 30, 2024
SQUAREPOINT OPS LLC0.15%0.00%70,59970,599100.00%96,721Jun 30, 2024
HRT FINANCIAL LP0.13%0.00%62,79662,796100.00%86,000Jun 30, 2024
FMR LLC0.11%-51,64348,2701431.07%70,751Jun 30, 2024
VERITION FUND MANAGEMENT LLC0.09%0.00%42,20042,200100.00%57,814Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.07%0.00%33,20033,200100.00%45,484Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.06%0.00%27,22027,220100.00%37,291Jun 30, 2024

As of Jun 30 2024, BioAtla's largest institutional buyer is MILLENNIUM MANAGEMENT LLC. The company purchased 775.61K stocks of BCAB, valued at $2.26M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.1.65%-791,560-1,988,141-71.52%1,084,438Jun 30, 2024
CORMORANT ASSET MANAGEMENT, LP----1,170,870-100.00%-Jun 30, 2024
STATE STREET CORP0.29%-139,606-651,672-82.36%191,260,000Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.84%-404,565-518,373-56.17%554,397Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC1.30%0.00%625,500-370,800-37.22%856,935Jun 30, 2024
VANGUARD GROUP INC3.92%-1,885,252-213,785-10.18%2,582,795Jun 30, 2024
UBS OCONNOR LLC----209,770-100.00%-Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC----177,852-100.00%-Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.8.11%0.47%3,901,314-163,883-4.03%5,344,800Jun 30, 2024
WOODLINE PARTNERS LP----133,214-100.00%-Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.16%0.00%74,667-128,422-63.23%102,294Jun 30, 2024
BANK OF NEW YORK MELLON CORP----122,516-100.00%-Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC----119,549-100.00%-Jun 30, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.0.24%0.00%117,552-116,385-49.75%161,046Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC2.86%0.19%1,374,076-100,000-6.78%1,882,484Jun 30, 2024
SQUAREPOINT OPS LLC----92,500-100.00%-Jun 30, 2024
PANAGORA ASSET MANAGEMENT INC----89,072-100.00%-Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC0.16%0.00%75,031-80,157-51.65%102,000Jun 30, 2024
MYDA ADVISORS LLC0.21%0.03%100,000-80,000-44.44%137,000Jun 30, 2024
CHASE INVESTMENT COUNSEL CORP----76,742-100.00%-Jun 30, 2024

As of Jun 30 2024, BioAtla's biggest institutional seller is BLACKROCK INC.. The company sold -1.99M shares of BCAB, valued at $1.08M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
AQR CAPITAL MANAGEMENT LLC1.32%0.00%636,136636,136100.00%871,507Jun 30, 2024
SCION ASSET MANAGEMENT, LLC1.32%1.65%633,959633,959100.00%868,524Jun 30, 2024
NORGES BANK1.02%0.00%488,191488,191100.00%668,822Jun 30, 2024
Y-INTERCEPT (HONG KONG) LTD0.34%0.01%161,871161,871100.00%221,763Jun 30, 2024
ALPINE GLOBAL MANAGEMENT, LLC0.32%0.04%154,417154,417100.00%211,551Jun 30, 2024
PALOMA PARTNERS MANAGEMENT CO0.20%0.00%97,17697,176100.00%133,131Jun 30, 2024
CENTIVA CAPITAL, LP0.19%0.00%90,40090,400100.00%123,848Jun 30, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.0.15%0.02%72,19372,193100.00%98,905Jun 30, 2024
SQUAREPOINT OPS LLC0.15%0.00%70,59970,599100.00%96,721Jun 30, 2024
HRT FINANCIAL LP0.13%0.00%62,79662,796100.00%86,000Jun 30, 2024
VERITION FUND MANAGEMENT LLC0.09%0.00%42,20042,200100.00%57,814Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.07%0.00%33,20033,200100.00%45,484Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.06%0.00%27,22027,220100.00%37,291Jun 30, 2024
VALMARK ADVISERS, INC.0.05%0.00%25,12625,126100.00%34,423Jun 30, 2024
GROUND SWELL CAPITAL, LLC0.05%0.03%24,06324,063100.00%32,966Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.05%0.00%22,77822,778100.00%31,206Jun 30, 2024
POINT72 (DIFC) LTD0.04%0.00%17,26117,261100.00%23,647Jun 30, 2024
UNITED BANK0.03%0.00%13,00013,000100.00%17,810Jun 30, 2024
NEUBERGER BERMAN GROUP LLC0.02%-10,84610,846100.00%14,859Jun 30, 2024
CWM, LLC0.01%-5,2995,299100.00%7,000Jun 30, 2024
MACQUARIE GROUP LTD0.00%-2,2712,271100.00%3,111Jun 30, 2024
SRS CAPITAL ADVISORS, INC.0.00%0.00%1,6951,695100.00%2,323Jun 30, 2024
REDWOOD WEALTH MANAGEMENT GROUP, LLC0.00%0.00%500500100.00%685Jun 30, 2024

BioAtla's largest new institutional shareholder by number of shares is AQR CAPITAL MANAGEMENT LLC, purchased 636.14K shares, valued at $871.51K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CORMORANT ASSET MANAGEMENT, LP----1,170,870-100.00%-Jun 30, 2024
UBS OCONNOR LLC----209,770-100.00%-Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC----177,852-100.00%-Jun 30, 2024
WOODLINE PARTNERS LP----133,214-100.00%-Jun 30, 2024
BANK OF NEW YORK MELLON CORP----122,516-100.00%-Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC----119,549-100.00%-Jun 30, 2024
SQUAREPOINT OPS LLC----92,500-100.00%-Jun 30, 2024
PANAGORA ASSET MANAGEMENT INC----89,072-100.00%-Jun 30, 2024
CHASE INVESTMENT COUNSEL CORP----76,742-100.00%-Jun 30, 2024
MANATUCK HILL PARTNERS, LLC----75,000-100.00%-Jun 30, 2024
SIMPLEX TRADING, LLC----43,239-100.00%-Jun 30, 2024
PATHSTONE HOLDINGS, LLC----34,301-100.00%-Jun 30, 2024
KENNEDY CAPITAL MANAGEMENT LLC----31,408-100.00%-Jun 30, 2024
BARCLAYS PLC----31,202-100.00%-Jun 30, 2024
VIRTU FINANCIAL LLC----30,012-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----21,799-100.00%-Jun 30, 2024
ENVESTNET ASSET MANAGEMENT INC----21,572-100.00%-Jun 30, 2024
INVESCO LTD.----20,376-100.00%-Jun 30, 2024
GSA CAPITAL PARTNERS LLP----17,722-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----15,595-100.00%-Jun 30, 2024
VOYA INVESTMENT MANAGEMENT LLC----14,805-100.00%-Jun 30, 2024
MANUFACTURERS LIFE INSURANCE COMPANY, THE----13,402-100.00%-Jun 30, 2024
SG AMERICAS SECURITIES, LLC----13,069-100.00%-Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/----12,791-100.00%-Jun 30, 2024
STATE OF WISCONSIN INVESTMENT BOARD----12,400-100.00%-Jun 30, 2024
BELVEDERE TRADING LLC----11,734-100.00%-Jun 30, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM----4,447-100.00%-Jun 30, 2024
LEGAL & GENERAL GROUP PLC----4,239-100.00%-Jun 30, 2024
AMERITAS INVESTMENT PARTNERS, INC.----3,653-100.00%-Jun 30, 2024
AMALGAMATED BANK----1,491-100.00%-Jun 30, 2024
ZURCHER KANTONALBANK (ZURICH CANTONALBANK)----477-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----8-100.00%-Jun 30, 2024

BioAtla's largest sold out institutional shareholder by shares sold is CORMORANT ASSET MANAGEMENT, LP, sold -1.17M shares, valued at -, as of undefined.

BioAtla Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
DEUTSCHE DWS INVESTMENT TRUST0.22%670,000325,58894.53%Mar 31, 2024
CORNERCAP GROUP OF FUNDS /VA/0.18%13,010-7,804-37.49%Sep 30, 2022
HARTFORD HLS SERIES FUND II INC0.13%30,781--Dec 31, 2023
T. Rowe Price New Horizons Fund, Inc.0.07%368,754--Mar 31, 2024
FIDELITY ADVISOR SERIES VII0.06%509,990--Jan 31, 2024
BlackRock Health Sciences Trust II0.05%138,461--Mar 31, 2024
Humankind Benefit Corp0.05%1,149--Dec 31, 2023
WASATCH FUNDS TRUST0.05%477,738--Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.04%22,308--Mar 31, 2024
FIDELITY MT VERNON STREET TRUST0.04%1,211,533--Feb 29, 2024
BRIDGEWAY FUNDS INC0.04%90,000-10,000-10.00%Mar 28, 2024
TIAA SEPARATE ACCOUNT VA 10.03%6,511--Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND IV0.02%67,000--Mar 31, 2024
FIDELITY CAPITAL TRUST0.02%201,294--Jan 31, 2024
MFS SERIES TRUST I0.02%339,507--Feb 29, 2024
QUANTITATIVE MASTER SERIES LLC0.01%73,127--Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%6,915--Mar 31, 2024
Collaborative Investment Series Trust0.01%1,228--Mar 31, 2024
Fidelity Central Investment Portfolios LLC0.01%280,000--Feb 29, 2024
ETFis Series Trust I0.01%7,475--Jan 31, 2024
VANGUARD INDEX FUNDS0.00%1,815,366-543,554-23.04%Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.00%274,398--Feb 29, 2024
Nushares ETF Trust0.00%27,646--Jan 31, 2024
MFS VARIABLE INSURANCE TRUST0.00%106,1935950.56%Mar 31, 2024
CLEARWATER INVESTMENT TRUST0.00%32,711--Mar 28, 2024
SCHWAB CAPITAL TRUST0.00%119,549--Jan 31, 2024
MFS VARIABLE INSURANCE TRUST III0.00%47,191--Mar 31, 2024
ALPS ETF Trust0.00%31,334--Feb 29, 2024
FIDELITY SECURITIES FUND0.00%159,677--Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.00%361,93735,62110.92%Feb 29, 2024
JANUS INVESTMENT FUND0.00%486,009--Dec 31, 2023
Calvert Variable Products, Inc.0.00%3,653--Mar 31, 2024
Managed Portfolio Series0.00%29,805--Mar 31, 2024
HARTFORD SERIES FUND INC0.00%39,177--Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%27,020-1,972-6.80%Mar 31, 2024
Direxion Shares ETF Trust0.00%98,047--Jan 31, 2024
MML SERIES INVESTMENT FUND0.00%5,675--Dec 31, 2023
BlackRock ETF Trust0.00%466--Jan 31, 2024
FIDELITY COVINGTON TRUST0.00%9,529--Jan 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%14,805-3,054-17.10%Mar 31, 2024
Forethought Variable Insurance Trust0.00%1,936--Mar 28, 2024
Principal Exchange-Traded Funds0.00%4,143--Mar 31, 2024
HC CAPITAL TRUST0.00%11,191--Mar 31, 2024
HARTFORD MUTUAL FUNDS II INC0.00%53,396--Jan 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%1,541--Mar 31, 2024
TIAA-CREF LIFE FUNDS0.00%824--Mar 31, 2024
VANGUARD WORLD FUND0.00%69,721--Feb 29, 2024
Trust for Advised Portfolios0.00%5,577--Dec 31, 2023
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%13,600--Mar 31, 2024
MUTUAL FUND SERIES TRUST0.00%795,000--Mar 31, 2024
NORTHWESTERN MUTUAL SERIES FUND INC0.00%18,281--Mar 31, 2024
SCHWAB STRATEGIC TRUST0.00%91,495--Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%1,817--Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.00%3,2811,10250.57%Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%121,807-32,594-21.11%Jan 31, 2024
NORTHERN FUNDS0.00%16,234-3,375-17.21%Mar 28, 2024
AMERICAN CENTURY ETF TRUST0.00%12,5971,76716.32%Feb 29, 2024
Dimensional ETF Trust0.00%42,741-16,857-28.28%Jan 31, 2024
RYDEX SERIES FUNDS0.00%404--Dec 31, 2023
VANGUARD SCOTTSDALE FUNDS0.00%192,74022,54513.25%Feb 29, 2024
iSHARES TRUST0.00%1,553,032-94,045-5.71%Mar 31, 2024
EQ ADVISORS TRUST0.00%87,588--Mar 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%9,0431,71223.35%Jan 31, 2024
PENN SERIES FUNDS INC0.00%1,800--Mar 28, 2024
VALIC Co I0.00%16,975-68-0.40%Feb 29, 2024
RBB FUND, INC.0.00%5,083--Feb 29, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%57,480--Mar 31, 2024
TIAA-CREF FUNDS0.00%164,530--Jan 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%6,618--Mar 31, 2024
RYDEX DYNAMIC FUNDS0.00%200--Dec 31, 2023
ALLSPRING MASTER TRUST0.00%3,169--Feb 29, 2024
Blackstone Alternative Investment Funds0.00%4,7003006.82%Mar 31, 2024
FIDELITY INVESTMENT TRUST0.00%7,700--Jan 31, 2024
MFS SERIES TRUST XV0.00%728-16-2.15%Jan 31, 2024
FLEXSHARES TRUST0.00%2,509--Jan 31, 2024
ProFunds0.00%343-29-7.80%Mar 31, 2024
PROSHARES TRUST0.00%6,479-2,285-26.07%Feb 29, 2024
HARTFORD MUTUAL FUNDS INC/CT0.00%201,491--Jan 31, 2024
SPDR SERIES TRUST0.00%865,970--Mar 31, 2024
RYDEX VARIABLE TRUST0.00%26--Dec 31, 2023
MASSMUTUAL SELECT FUNDS0.00%23,337--Dec 31, 2023
VICTORY PORTFOLIOS0.00%665--Mar 31, 2024
PACIFIC FUNDS SERIES TRUST0.00%5,3372,03461.58%Mar 31, 2023
MFS SERIES TRUST X0.00%177,838--Jan 31, 2024
Brighthouse Funds Trust II0.00%15,887--Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%3,940--Jan 31, 2024
PACIFIC SELECT FUND0.00%58,606-3,165-5.12%Mar 31, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%1,566--Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%37,900--Mar 31, 2024
Guggenheim Active Allocation Fund0.00%92--Feb 29, 2024
SUNAMERICA SERIES TRUST0.00%5,011-21-0.42%Jan 31, 2024
J.P. Morgan Exchange-Traded Fund Trust0.00%5,357--Jan 31, 2024
ADVANCED SERIES TRUST0.00%38,828--Mar 28, 2024
MASTER INVESTMENT PORTFOLIO0.00%948--Mar 31, 2024
SEI INSTITUTIONAL MANAGED TRUST0.00%30,910--Dec 31, 2023
FIDELITY SALEM STREET TRUST0.00%32,840-1,240-3.64%Mar 31, 2024
SPDR INDEX SHARES FUNDS0.00%1,260--Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%13,3425,25064.88%Mar 31, 2024
ETF Series Solutions0.00%106--Jan 31, 2024
Bridge Builder Trust0.00%17,917--Mar 31, 2024

BioAtla's largest mutual fund holder by % of total assets is "DEUTSCHE DWS INVESTMENT TRUST", owning 670.00K shares, compromising 0.22% of its total assets.

BioAtla Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2481-7.95%
31 Mar, 248811.39%
31 Dec, 2379-4.82%
30 Sep, 2383-5.68%
30 Jun, 23888.64%
31 Mar, 2381-12.90%
31 Dec, 229325.68%
30 Sep, 2274-2.63%
30 Jun, 2276-21.65%
31 Mar, 229716.87%
31 Dec, 2183-3.49%
30 Sep, 218613.16%
30 Jun, 217622.58%
31 Mar, 216216.98%
31 Dec, 2053-

As of 30 Jun 24, 81 institutions are holding BioAtla's shares, representing a decrease of -7.95% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2422,123,953-11.03%
31 Mar, 2424,866,065-7.77%
31 Dec, 2326,962,093-8.92%
30 Sep, 2329,602,266-7.49%
30 Jun, 2331,997,498-2.11%
31 Mar, 2332,688,711-3.68%
31 Dec, 2233,937,97837.04%
30 Sep, 2224,765,2575.28%
30 Jun, 2223,523,082-7.86%
31 Mar, 2225,529,462-3.33%
31 Dec, 2126,410,1064.15%
30 Sep, 2125,358,24519.81%
30 Jun, 2121,165,64611.38%
31 Mar, 2119,002,88421.31%
31 Dec, 2015,664,281-

BioAtla (BCAB) has 22.12M shares outstanding as of 30 Jun 24, down -11.03% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2446.01%1.70%
31 Mar, 2452.05%1.64%
31 Dec, 2356.37%1.46%
30 Sep, 2362.05%1.37%
30 Jun, 2367.25%1.42%
31 Mar, 2368.70%0.90%
31 Dec, 2287.18%2.00%
30 Sep, 2266.01%1.67%
30 Jun, 2262.86%1.34%
31 Mar, 2268.40%1.17%
31 Dec, 2176.42%1.37%
30 Sep, 2174.78%1.89%
30 Jun, 2162.85%1.97%
31 Mar, 2156.45%2.61%
31 Dec, 2046.53%-

As of 30 Jun 24, BioAtla is held by 46.01% institutional shareholders, representing a 1.70% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2442-
31 Mar, 24427.69%
31 Dec, 233914.71%
30 Sep, 2334-39.29%
30 Jun, 235619.15%
31 Mar, 2347-24.19%
31 Dec, 226251.22%
30 Sep, 224120.59%
30 Jun, 2234-44.26%
31 Mar, 226124.49%
31 Dec, 2149-16.95%
30 Sep, 215937.21%
30 Jun, 21432.38%
31 Mar, 2142-20.75%
31 Dec, 2053-

42 institutional shareholders have increased their position in BCAB stock as of 30 Jun 24 compared to 42 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2429-3.33%
31 Mar, 243015.38%
31 Dec, 2326-13.33%
30 Sep, 2330114.29%
30 Jun, 2314-22.22%
31 Mar, 231812.50%
31 Dec, 2216-30.43%
30 Sep, 2223-30.30%
30 Jun, 223365.00%
31 Mar, 222025.00%
31 Dec, 2116-5.88%
30 Sep, 2117-5.56%
30 Jun, 211850.00%
31 Mar, 2112-
31 Dec, 20--

29 institutional shareholders have reduced their position in BCAB stock as of 30 Jun 24 compared to 30 in the previous quarter (a -3.33% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2481-7.95%22,123,953-11.03%46.01%1.70%42-29-3.33%
31 Mar, 248811.39%24,866,065-7.77%52.05%1.64%427.69%3015.38%
31 Dec, 2379-4.82%26,962,093-8.92%56.37%1.46%3914.71%26-13.33%
30 Sep, 2383-5.68%29,602,266-7.49%62.05%1.37%34-39.29%30114.29%
30 Jun, 23888.64%31,997,498-2.11%67.25%1.42%5619.15%14-22.22%
31 Mar, 2381-12.90%32,688,711-3.68%68.70%0.90%47-24.19%1812.50%
31 Dec, 229325.68%33,937,97837.04%87.18%2.00%6251.22%16-30.43%
30 Sep, 2274-2.63%24,765,2575.28%66.01%1.67%4120.59%23-30.30%
30 Jun, 2276-21.65%23,523,082-7.86%62.86%1.34%34-44.26%3365.00%
31 Mar, 229716.87%25,529,462-3.33%68.40%1.17%6124.49%2025.00%
31 Dec, 2183-3.49%26,410,1064.15%76.42%1.37%49-16.95%16-5.88%
30 Sep, 218613.16%25,358,24519.81%74.78%1.89%5937.21%17-5.56%
30 Jun, 217622.58%21,165,64611.38%62.85%1.97%432.38%1850.00%
31 Mar, 216216.98%19,002,88421.31%56.45%2.61%42-20.75%12-
31 Dec, 2053-15,664,281-46.53%-53---

BioAtla Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 01, 2024Smith Scott Andrewdirector-F-InKindSell2,181$1.81$3.95K300,231
Aug 01, 2024Sievers Ericofficer Chief Medical OfficerF-InKindSell572$1.81$1.04K208,134
Jul 01, 2024Smith Scott Andrewdirector-F-InKindSell2,181$1.37$2.99K302,412
Jul 01, 2024Sievers Ericofficer Chief Medical OfficerF-InKindSell572$1.37$783.64208,706
May 31, 2024Smith Scott Andrewdirector-F-InKindSell2,181$1.51$3.29K288,093
May 31, 2024Sievers Ericofficer Chief Medical OfficerF-InKindSell572$1.51$863.72209,278
May 01, 2024Sievers Ericofficer Chief Medical OfficerF-InKindSell572$2.26$1.29K209,850
May 01, 2024Smith Scott Andrewdirector-F-InKindSell2,181$2.26$4.93K290,274
Apr 01, 2024Smith Scott Andrewdirector-F-InKindSell2,181$3.44$7.50K292,455
Apr 01, 2024Sievers Ericofficer Chief Medical OfficerF-InKindSell572$3.44$1.97K210,422
Mar 01, 2024Smith Scott Andrewdirector-F-InKindSell2,181$2.70$5.89K294,636
Mar 01, 2024Sievers Ericofficer Chief Medical OfficerF-InKindSell572$2.70$1.54K210,994

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 01, 2024Smith Scott Andrewdirector-F-InKindSell2,181$1.81$3.95K300,231
Aug 01, 2024Sievers Ericofficer Chief Medical OfficerF-InKindSell572$1.81$1.04K208,134
Jul 01, 2024Smith Scott Andrewdirector-F-InKindSell2,181$1.37$2.99K302,412
Jul 01, 2024Sievers Ericofficer Chief Medical OfficerF-InKindSell572$1.37$783.64208,706
Jun 14, 2024GRAY MARY ANNdirector-A-AwardBuy16,500--53,897
Jun 14, 2024MCBRINN SYLVIAdirector-A-AwardBuy16,500--35,625
Jun 14, 2024Smith Scott Andrewdirector-A-AwardBuy16,500--304,593
Jun 14, 2024STEINMAN LAWRENCEdirector-A-AwardBuy16,500--54,959
Jun 14, 2024Williams Eddiedirector-A-AwardBuy16,500--36,700
Jun 14, 2024Moran Susandirector-A-AwardBuy16,500--28,807
May 31, 2024Smith Scott Andrewdirector-F-InKindSell2,181$1.51$3.29K288,093
May 31, 2024Sievers Ericofficer Chief Medical OfficerF-InKindSell572$1.51$863.72209,278
May 01, 2024Sievers Ericofficer Chief Medical OfficerF-InKindSell572$2.26$1.29K209,850
May 01, 2024Smith Scott Andrewdirector-F-InKindSell2,181$2.26$4.93K290,274
Apr 01, 2024Smith Scott Andrewdirector-F-InKindSell2,181$3.44$7.50K292,455
Apr 01, 2024Sievers Ericofficer Chief Medical OfficerF-InKindSell572$3.44$1.97K210,422
Mar 01, 2024Smith Scott Andrewdirector-F-InKindSell2,181$2.70$5.89K294,636
Mar 01, 2024Sievers Ericofficer Chief Medical OfficerF-InKindSell572$2.70$1.54K210,994
Feb 20, 2024WALDRON RICHARD Aofficer Chief Financial OfficerA-AwardBuy106,000--230,923
Feb 20, 2024Vasquez Christianofficer See RemarksA-AwardBuy70,000--185,659

The last insider sell of BioAtla's stock was made by Smith Scott Andrew on Aug 01 2024, selling 2,181 shares at $1.81 per share (valued at $3.95K).

BioAtla Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-2-
Q2 202466100.00%
Q1 20244666.67%
Q4 20236966.67%
Q3 202331520.00%
Q2 202391560.00%
Q1 2023101566.67%
Q4 202221513.33%
Q3 20221156.67%
Q2 2022111573.33%
Q1 202251533.33%
Q4 20211831.20%
Q3 202131225.00%
Q2 2021151883.33%
Q4 2020121580.00%

0 total buy trades, and 2 total sell trades (buy/sell ratio of 0.00%) were made by BioAtla's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024---
Q2 2024---
Q1 2024---
Q4 20234--
Q3 20231--
Q2 2023---
Q1 20233--
Q4 20222--
Q3 20221--
Q2 20223--
Q1 2022---
Q4 2021-78-
Q3 2021-11-
Q2 2021-16-
Q4 20203--

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of BioAtla's stocks.

BioAtla Peer Ownership


TickerCompany
GRCLGracell Biotechnologies Inc.
OLMAOlema Pharmaceuticals, Inc.
NRIXNurix Therapeutics, Inc.
PMVPPMV Pharmaceuticals, Inc.
KYMRKymera Therapeutics, Inc.
IKNAIkena Oncology, Inc.
FHTXFoghorn Therapeutics Inc.
IPSCCentury Therapeutics, Inc.
AVTEAerovate Therapeutics, Inc.
ERASErasca, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
PASGPassage Bio, Inc.
ANTXAN2 Therapeutics, Inc.
CCCCC4 Therapeutics, Inc.
GLUEMonte Rosa Therapeutics, Inc.
DSGNDesign Therapeutics, Inc.
RZLTRezolute, Inc.
ADAGAdagene Inc.
NAUTNautilus Biotechnology, Inc.
STTKShattuck Labs, Inc.

BCAB Ownership FAQ


BioAtla is owned by institutional shareholders (46.01%), insiders (10.76%), and public (43.23%). The largest institutional shareholder of BioAtla is SOLEUS CAPITAL MANAGEMENT, L.P. (8.11% of total shares) and the top mutual fund owner is DEUTSCHE DWS INVESTMENT TRUST (0.22% of total shares).

BioAtla's major institutional shareholders are SOLEUS CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, and TANG CAPITAL MANAGEMENT LLC. The top five shareholders own together 22.18% of the company's share outstanding.

As of Jun 2024, there are 81 institutional shareholders of BioAtla.

SOLEUS CAPITAL MANAGEMENT, L.P owns 3.9M shares of BioAtla, representing 8.11% of the company's total shares outstanding, valued at $5.34M (as of Jun 2024).

As of Jun 2024, VANGUARD GROUP INC holds 1.89M shares of BioAtla (BCAB), compromising 3.92% of the company, valued at $2.58M.

MORGAN STANLEY is the third largest holder of BioAtla. The company owns 1.85M of the company's shares outstanding (worth $2.54M).